In this episode of Base to Base Biotech, join our CEO, Sean A. MacDonald, in conversation with Jim Cornall as he explores our platform breakthroughs, pipeline progress, and clinical vision delivering new therapeutic options for patients with hard-to-treat diseases. Hear how strategic optionality and patient impact fuel our momentum. Listen now
